Skip to content

NB CARE

Active
Private limited companyfounded 2020active for 6 yearsZavelstraat 28, 1800 Vilvoorde, BelgiumKBO/BCE: BE 0754.463.921
Summary

NB CARE has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €136,382 and a net result of €35,600. Equity is growing by about 24% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).

History

NB CARE was incorporated on 16 September 2020 as a private limited company.1 Turnover grew from €170,008 in 2022 to €271,990 in 2024.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2022 and 2024

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
06-07
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial Weakest financial yearnet €35,600 ▼66.3%
Net result drops to €35,600, the lowest in the series.
31-12
Financial Liquidity more than 6 timescurrent ratio 13.53
Current ratio from 2.21 to 13.53; short-term debt falls from €82,326 to €10,303.
03-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Highest result from 2021 to 2025net €105,551 ▲85.2%
Operating result €121,306, net result €105,551, both a record.
31-12
Financial Equity above €100,000equity €100,782 ▲67.3%
A profit in every financial year since 2021 builds equity to €100,782.
19-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 19 days late
2023
29-09
NBB filing Annual accounts filed
financial year 2022 · full format · 16 days late
16-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 16 days late
2022
29-08
NBB filing Annual accounts filed
financial year 2021 · micro format · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts

We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.